Novel alternatives to conventional in-vitro-cancer models using 3D-bioprinting technology

Introduction 3D-bioprinting, an evolving biofabrication technique in regenerative medicine & tissue engineering with the prospect of mimicking the native tumour niche. The aim of this pilot study was to determine the optimal bioprinting parameters and to compare different nanocellulose (NC) based bioinks suitable to fabricate a 3D-bioprinted head and neck squamous cell carcinoma (HNSCC) model.